To improve the efficacy of antiangiogenic drugs, alternative angiogenic pathways need to be targeted along with the VEGF signalling pathway, or a combination of antiangiogenic therapy with chemo- or radiotherapy could be an effective solution to achieve optimal inhibition of cancer angiogenesis [82]. This evidence concerns the gene VEGFA and cancer.